Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Gene polymorphism in Netherton and common atopic disease.

Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, Wong K, Abecasis GR, Jones EY, Harper JI, Hovnanian A, Cookson WO.

Nat Genet. 2001 Oct;29(2):175-8.

PMID:
11544479
2.

Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese.

Nishio Y, Noguchi E, Shibasaki M, Kamioka M, Ichikawa E, Ichikawa K, Umebayashi Y, Otsuka F, Arinami T.

Genes Immun. 2003 Oct;4(7):515-7.

PMID:
14551605
3.

Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population.

Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M.

Br J Dermatol. 2003 Apr;148(4):665-9.

PMID:
12752122
4.

Polymorphisms in SPINK5 are not associated with asthma in a Dutch population.

Jongepier H, Koppelman GH, Nolte IM, Bruinenberg M, Bleecker ER, Meyers DA, te Meerman GJ, Postma DS.

J Allergy Clin Immunol. 2005 Mar;115(3):486-92.

PMID:
15753894
5.
6.

Hint for association of single nucleotide polymorphisms and haplotype in SPINK5 gene with atopic dermatitis in Koreans.

Namkung JH, Lee JE, Kim E, Byun JY, Kim S, Shin ES, Cho EY, Yang JM.

Exp Dermatol. 2010 Dec;19(12):1048-53. doi: 10.1111/j.1600-0625.2010.01142.x.

PMID:
21087323
7.

Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China.

Zhao LP, Di Z, Zhang L, Wang L, Ma L, Lv Y, Hong Y, Wei H, Chen HD, Gao XH.

J Eur Acad Dermatol Venereol. 2012 May;26(5):572-7. doi: 10.1111/j.1468-3083.2011.04120.x. Epub 2011 May 18.

PMID:
21585560
8.

SPINK5: both rare and common skin disease.

Norgett EE, Kelsell DP.

Trends Mol Med. 2002 Jan;8(1):7. Review. No abstract available.

PMID:
11796258
9.

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.

Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A.

Nat Genet. 2000 Jun;25(2):141-2.

PMID:
10835624
10.

The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis.

Sprecher E, Chavanas S, DiGiovanna JJ, Amin S, Nielsen K, Prendiville JS, Silverman R, Esterly NB, Spraker MK, Guelig E, de Luna ML, Williams ML, Buehler B, Siegfried EC, Van Maldergem L, Pfendner E, Bale SJ, Uitto J, Hovnanian A, Richard G.

J Invest Dermatol. 2001 Aug;117(2):179-87.

11.

Biochemical features, molecular biology and clinical relevance of the human 15-domain serine proteinase inhibitor LEKTI.

Walden M, Kreutzmann P, Drögemüller K, John H, Forssmann WG, Hans-Jürgen M.

Biol Chem. 2002 Jul-Aug;383(7-8):1139-41. Review.

PMID:
12437098
12.

hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.

Egelrud T, Brattsand M, Kreutzmann P, Walden M, Vitzithum K, Marx UC, Forssmann WG, Mägert HJ.

Br J Dermatol. 2005 Dec;153(6):1200-3.

PMID:
16307658
13.

LEKTI, a novel 15-domain type of human serine proteinase inhibitor.

Mägert HJ, Ständker L, Kreutzmann P, Zucht HD, Reinecke M, Sommerhoff CP, Fritz H, Forssmann WG.

J Biol Chem. 1999 Jul 30;274(31):21499-502.

14.

LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.

Ong C, O'Toole EA, Ghali L, Malone M, Smith VV, Callard R, Harper JI.

Br J Dermatol. 2004 Dec;151(6):1253-7.

PMID:
15606522
15.

The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.

Mägert HJ, Kreutzmann P, Drögemüller K, Ständker L, Adermann K, Walden M, John H, Korting HC, Forssmann WG.

Eur J Med Res. 2002 Feb 21;7(2):49-56. Review.

PMID:
11891144
16.

Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis.

Roedl D, Traidl-Hoffmann C, Ring J, Behrendt H, Braun-Falco M.

J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1263-6. doi: 10.1111/j.1468-3083.2009.03302.x. Epub 2009 Jun 1.

PMID:
19522716
17.

LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.

Vitzithum K, Lauber T, Kreutzmann P, Schulz A, Sommerhoff CP, Rösch P, Marx UC.

Protein Expr Purif. 2008 Jan;57(1):45-56. Epub 2007 Sep 5.

PMID:
17936012
18.

Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.

Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL.

Biochemistry. 2003 Apr 8;42(13):3874-81.

PMID:
12667078
19.

LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.

Mägert HJ, Kreutzmann P, Ständker L, Walden M, Drögemüller K, Forssmann WG.

Int J Biochem Cell Biol. 2002 Jun;34(6):573-6. Review.

PMID:
11943586
20.

Supplemental Content

Support Center